Published in Medical Imaging Law Weekly, August 2nd, 2005
"Although EUS provides superior local staging of esophageal carcinoma when compared with other tests, EUS seems to be underused by physicians," argued researchers in the United States, who performed a "prospective study to determine whether EUS is ordered in the evaluation of esophageal cancer and whether staging information obtained would change management."
"A total of 114 physicians were mailed a questionnaire that surveyed which tests are used in evaluating patients with esophageal cancer, the order in which they are requested, and their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.